InMed Pharmaceuticals Inc. (INM) is priced at $1.51 after the most recent trading session. At the very opening of the session, the stock price was $1.45 and reached a high price of $1.5048, prior to closing the session it reached the value of $1.47. The stock touched a low price of $1.45.Recently in News on October 13, 2021, InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids. InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing and clinical development of rare cannabinoids, today announced that they have completed the previously announced acquisition of BayMedica Inc. (“BayMedica”), a private company based in the US specializing in the manufacturing and commercialization of rare cannabinoids for the health and wellness sector. You can read further details here
InMed Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $6.4200 on 02/03/21, with the lowest value was $1.4300 for the same time period, recorded on 10/12/21.
InMed Pharmaceuticals Inc. (INM) full year performance was -58.88%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, InMed Pharmaceuticals Inc. shares are logging -83.11% during the 52-week period from high price, and 5.59% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.43 and $8.94.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 894395 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the InMed Pharmaceuticals Inc. (INM) recorded performance in the market was -55.32%, having the revenues showcasing -44.94% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 11.83M, as it employees total of 13 workers.
Market experts do have their say about InMed Pharmaceuticals Inc. (INM)
During the last month, 0 analysts gave the InMed Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.4376, with a change in the price was noted -1.24. In a similar fashion, InMed Pharmaceuticals Inc. posted a movement of -45.26% for the period of last 100 days, recording 171,937 in trading volumes.
Technical breakdown of InMed Pharmaceuticals Inc. (INM)
Raw Stochastic average of InMed Pharmaceuticals Inc. in the period of last 50 days is set at 5.79%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 7.46%. In the last 20 days, the company’s Stochastic %K was 5.33% and its Stochastic %D was recorded 4.89%.
Bearing in mind the latest performance of InMed Pharmaceuticals Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -55.32%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -51.49%, alongside a downfall of -58.88% for the period of the last 12 months. The shares increased approximately by -2.65% in the 7-day charts and went up by -28.29% in the period of the last 30 days. Common stock shares were lifted by -44.94% during last recorded quarter.